Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 11 clinical trials
Featured trial
Have been diagnosed with moderate to severe Ulcerative Colitis?

Have been diagnosed with moderate to severe Ulcerative Colitis?

  • 72 views
  • 08 Nov, 2020
  • 1 location
Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis (PEAPOD)

The study will aim to estimate the efficacy of apremilast compared with placebo in the treatment of juvenile psoriatic arthritis (JPsA) in pediatric participants 5 to less than 18 years of age

  • 0 views
  • 05 May, 2022
  • 18 locations
Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis. (FOREMOST)

This clinical study will test the effects of a drug called apremilast in oligoarticular psoriatic arthritis with less than 5 years of disease duration. In previous studies, apremilast has been

apremilast
  • 371 views
  • 25 Mar, 2022
  • 103 locations
Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease (BEAN)

The aim of this study is to estimate the efficacy of apremilast compared to placebo in the treatment of oral ulcers in pediatric participants from 2 to < 18 years of age with oral ulcers

  • 0 views
  • 10 Mar, 2022
  • 16 locations
A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

This study was created to provide subjects who complete Week 52 (end of Apremilast Extension Phase) of study CC-10004-PPSO-003 the option to continue to receive open-label apremilast therapy

tubal ligation
cc-10004
cervical cap
option 2
apremilast
  • 0 views
  • 26 May, 2022
  • 46 locations
Apremilast 30 mg BID Combined With Dupilumab

Open label phase 2 investigational study of efficacy and safety of apremilast 30 mg BID in chronic atopic dermatitis when added to the FDA approved treatment dupilumab for atopic dermatitis that

treatment regimen
vasectomy
atopy
dupilumab
  • 0 views
  • 02 Jun, 2021
  • 1 location
Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)

The primary objective of the study is to evaluate the efficacy of apremilast (AMG 407) twice daily (BID) compared with placebo in participants with Palmoplantar Pustulosis (PPP).

  • 0 views
  • 23 Apr, 2022
  • 20 locations
Molecular Effects of Apremilast in the Synovium of Psoriatic Arthritis Patients

This study assess the genomics profiles in synovial biopsies obtained prior to, and 24 weeks after an immunomodulator agent (Apremilast) in patients with active psoriatic arthritis who are naive

  • 2 views
  • 27 Jan, 2021
  • 1 location
The AP-GELP Study: A Clinical Trial on the Effects of Apremilast in Female Genital Erosive Lichen Planus

will study the effects of treatment with apremilast and quality of life and sexual function in women with GELP.

apremilast
  • 0 views
  • 29 Aug, 2021
  • 1 location
Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis

Psoriasis has been associated with an increasing risk for atherosclerosis. The investigators investigated whether surrogate markers of subclinical atherosclerosis, vascular dysfunction and myocardial dysfunction are impaired in patients with psoriasis compared to normal controls ,coronary artery disease patients and untreated hypertension subjects. The investigators also examined the effect of treatment …

etanercept
cyclosporine
ustekinumab
apremilast
secukinumab
  • 0 views
  • 18 Apr, 2022
  • 1 location